American Society of Hirudotherapy

Haemadin

Picomolar-affinity thrombin inhibitor from Indian buffalo leech — distinct mechanism from hirudin.

Preclinical / mechanistic: Evidence is preclinical (in vitro, animal models, or mechanism-of-action research). Clinical efficacy in humans has not been established.Last Updated: May 26, 2026 · ASH Editorial · based on the books
  • Hementerin80 kDa
  • Hementin80 kDa
  • Hementin-Like Protein (HLP-1)80 kDa
  • Leech Collagenase70 kDa
  • Haemadipsa yanyuanensis Progranulin (Hy-PGRN)70 kDa
  • Leech Apyrase67 kDa
  • Calin65 kDa
  • Hyaluronidase60 kDa
  • Antithrombin III binding protein58 kDa
  • Collagenolytic Fibrinolysin55 kDa
  • Leech Thrombospondin-Like Protein50 kDa
  • Haemadin5.2 kDa
Molecular weight (kilodaltons) of Haemadin (highlighted) alongside other characterized leech salivary compounds. Smaller proteins/peptides generally diffuse and act faster.

Mechanistic Evidence Box

Preclinical / mechanistic: Evidence is preclinical (in vitro, animal models, or mechanism-of-action research). Clinical efficacy in humans has not been established.
Page type
Compound profile
Evidence type
Preclinical / biochemical characterization
Evidence level
In vitro
Drug vs leech
Purified natural compound
Safety domains
Bleeding

Clinical translation limit

Haemadin's in vitro thrombin inhibition does not establish clinical efficacy. No FDA-approved derivative exists. Mechanism is preclinical/biochemical only.

Ribbon model of the three copies of the thrombin–haemadin complex in the crystal, side by side: three large thrombin molecules (orange, olive and green), each with a short light chain (blue tones) and a small, loosely folded haemadin molecule (purple tones) bound to its side.
Haemadin from the land leech Haemadipsa sylvestris in complex with human α-thrombin (PDB 1E0F, X-ray diffraction). Source: PDBe, EMBL-EBI — PDB 1E0F · PDBe public data (public domain)

Molecular Profile

Category
Anticoagulant
Evidence tier
Preclinical
Molecular weight
5,183 Da
Source species
Haemadipsa sylvestris
Discovered
1991 · Strube KH et al.
PDB structures
1E0F

Biological Targets

  • → thrombin (exosite I, non-exosite II)

Key Citations

  1. Strube KH et al. (1993), J Biol Chem · PMID 8473305

External Resources

Related Anticoagulant Compounds

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.